Abivax Operating Expenses Growth & History (ABVX)

Abivax's operating expenses was €250.6M for fiscal 2025.

View full Abivax company overview

Abivax annual operating expenses history

Abivax annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31€250.6M€65.2M+35.16%
20242024-12-31€185.4M€53.4M+40.48%
20232023-12-31€132.0M€62.6M+90.15%
20222022-12-31€69.4M€16.1M+30.09%
20212021-12-31€53.4M

Abivax operating expenses trends

Between the periods ended 2021-12-31 and 2025-12-31, Abivax's operating expenses increased from €53.4M to €250.6M, a change of €197.3M. The latest reported quarter, Q1 2026, shows €56.2M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Abivax source filings ↗

Community posts

It’s quiet here.

No posts about ABVX yet. Start the conversation.

Write the first post